Takeda Pharmaceutical Company Limited

Last updated September 27, 2026

Organization details

Legal name
Takeda Pharmaceutical Company Limited
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Headquarters city
Tokyo
Headquarters country
Japan
Ticker symbol
TAK
Primary stock exchange
NYSE

Identifiers

SEC CIK
0001395064

Board of directors

Chief executives

Julie So-Young Kim · President and CEO
Dates unknown
Christophe Pierre Weber · President and CEO
Since March 2026

Board connections

9 of this board's directors also sit on 26 other boards. 17 are in the same sector.

Network of Takeda Pharmaceutical Company Limited's board connections Boston Scientific Corporation Boston Scientific Corp... Agios Pharmaceuticals Inc. Agios Pharmaceuticals... Beam Therapeutics Inc. Beam Therapeutics Inc. BioMarin Pharmaceutical Inc. BioMarin Pharmaceutica... Blaize Holdings Inc. Blaize Holdings Inc. City Therapeutics Inc. City Therapeutics Inc. Corvus Pharmaceuticals Inc. Corvus Pharmaceuticals... GoodRx Holdings Inc. GoodRx Holdings Inc. Guardant Health Inc. Guardant Health Inc. HA Sustainable Infrastructure Capital Inc. HA Sustainable Infrast... HP Inc. HP Inc. Hemab Therapeutics Holdings Inc. Hemab Therapeutics Hol... Humana Inc. Humana Inc. KLA Corporation KLA Corporation Kardigan Inc. Kardigan Inc. Kymera Therapeutics Inc. Kymera Therapeutics In... Bruce D. Broussard Bruce D. Broussard Christophe Pierre Weber Christophe Pierre We... Emiko Higashi Emiko Higashi Ian T. Clark Ian T. Clark John Maraganore John Maraganore Kimberly A. Reed Kimberly A. Reed Steven Gillis Steven Gillis Yoshiaki Fujimori Yoshiaki Fujimori Takeda Pharmaceutical Comp...
Shared director Other board Same sector +10 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$15,224,704
22 sales by 13 insiders
Date Insider Transaction Shares Price Value
Nov 4, 2026 Platford Giles Richard Officer (President, IBU) Open-market sale −55,617 $20.90 $1,162,395
Nov 2, 2026 Teresa Marie Bitetti Officer (President, OBU) Open-market sale −46,609 $20.89 $973,662
Sep 14, 2026 Duprey Lauren Rusckowski Officer (Chief Transformation Officer) Open-market sale −34,535 $18.54 $640,279
Sep 2, 2026 Andrew Stewart Plump Director, Officer (President, R&D) Open-market sale −116,191 $18.49 $2,148,372
Aug 19, 2026 Andrew Stewart Plump Director, Officer (President, R&D) Open-market sale −19,651 $18.49 $363,347
Aug 18, 2026 Greenway Nicola Deidre Petal Officer (Chief Human Resources Officer) Open-market sale −12,980 $18.11 $235,068
Aug 11, 2026 Shannon Elaine Mary Officer (Pres., Global Supply & Quality) Open-market sale −20,363 $17.55 $357,371
Aug 10, 2026 Teresa Marie Bitetti Officer (President, OBU) Open-market sale −50,012 $17.10 $855,205
Aug 10, 2026 Duprey Lauren Rusckowski Officer (Chief Transformation Officer) Open-market sale −47,586 $17.10 $813,721
Aug 10, 2026 Farajallah Awny Samaan Botros Officer (Chief Medical Officer) Open-market sale −14,006 $17.10 $239,503
Aug 10, 2026 Furney Natalie Anne Marie Officer (Global General Counsel) Open-market sale −30,868 $17.10 $527,843
Aug 10, 2026 Greenway Nicola Deidre Petal Officer (Chief Human Resources Officer) Open-market sale −975 $17.50 $17,063
Aug 10, 2026 Greenway Nicola Deidre Petal Officer (Chief Human Resources Officer) Open-market sale −6,774 $17.10 $115,835
Aug 10, 2026 Ibrahim Ramy Riad Ahmed Officer (President, PDT BU) Open-market sale −7,277 $17.10 $124,437
Aug 10, 2026 Julie So-Young Kim Director, Officer (President and CEO) Open-market sale −89,090 $17.10 $1,523,439

Organizations in the same sector, closest in location and size first.

Questions about Takeda Pharmaceutical Company Limited

Who is the CEO of Takeda Pharmaceutical Company Limited?

Christophe Pierre Weber has been Takeda Pharmaceutical Company Limited's President and CEO since March 2026.

How many directors are on Takeda Pharmaceutical Company Limited's board?

Takeda Pharmaceutical Company Limited's board has 18 directors: Andrew Stewart Plump, Bruce D. Broussard, Christophe Pierre Weber, Emiko Higashi, Ian T. Clark, Jean Luc Butel, John Maraganore, Julie So-Young Kim, Kimberly A. Reed, Koichiro Kimura and 8 others.

Are Takeda Pharmaceutical Company Limited insiders buying or selling shares?

Over the last 12 months, Takeda Pharmaceutical Company Limited insiders made no open-market purchases and sold $15.2 million of shares in 22 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="takeda-pharmaceutical-company-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.